Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Cholestyramine
Drug ID BADD_D00451
Description Cholestyramine or colestyramine is a bile acid sequestrant. Bile acid sequestrants are polymeric compounds which serve as ion exchange resins. Cholestyramine resin is quite hydrophilic, but insoluble in water.
Indications and Usage Indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. Also for the relief of pruritus associated with partial biliary obstruction.
Marketing Status Prescription; Discontinued
ATC Code C10AC01
DrugBank ID DB01432
KEGG ID D02690
MeSH ID D002792
PubChem ID 137699107
TTD Drug ID Not Available
NDC Product Code 63629-2163; 46144-315; 0245-0536; 0185-0940; 42806-267; 68382-528; 42806-265; 49884-936; 0832-0536; 63629-2161; 50090-3415; 0245-0036; 49884-466; 62559-620; 71052-151; 53933-2175; 51224-009; 68444-0001; 70771-1105; 70771-1070; 68382-529; 63629-2162; 27241-134; 51927-4962; 42806-266; 51224-011; 63629-2164; 49884-465; 49884-937
Synonyms Cholestyramine Resin | Cholestyramine Resins | Resin, Cholestyramine | Resins, Cholestyramine | Colestyramin | Colestyramins | Colestyramine | Colestyramines | Cholestyramine | Cholestyramines | MK-135 | MK 135 | MK135 | Questran | Questrans | Cuemid | Cuemids | Quantalan | Quantalans
Chemical Information
Molecular Formula C27H47ClN2
CAS Registry Number 11041-12-6
SMILES CCC(C)C.CCC(CC(C)C1=CC=CC=C1)C2=CC=C(C=C2)C[N+](C)(C)C.N.[Cl-]
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dysuria20.02.02.002--
Ecchymosis23.06.01.001; 01.01.03.001; 24.07.06.002--Not Available
Eructation07.01.02.003--
Erythema23.03.06.001--Not Available
Faeces discoloured07.01.03.002--Not Available
Fatigue08.01.01.002--
Flatulence07.01.04.002--
Frequent bowel movements07.02.04.0020.002480%Not Available
Gait disturbance17.02.05.016; 08.01.02.0020.001654%
Gingival bleeding24.07.02.010; 07.09.07.001--Not Available
Glossitis07.14.01.001--Not Available
Haematochezia24.07.02.012; 07.12.02.0030.001654%Not Available
Haematuria24.07.01.047; 20.02.01.006--
Headache17.14.01.001--
Hepatic function abnormal09.01.02.001--Not Available
Hiccups22.02.04.002; 07.01.06.009--
Hypoprothrombinaemia01.01.01.001--Not Available
Intestinal obstruction07.13.01.0020.001654%Not Available
Libido increased21.03.02.007; 19.08.03.002--
Lymphadenopathy01.09.01.002--Not Available
Malaise08.01.01.0030.002480%
Muscle spasms15.05.03.0040.001654%
Myalgia15.05.02.001--
Nausea07.01.07.0010.007441%
Nephrolithiasis20.04.01.0020.001654%
Neuralgia17.02.07.005--
Night blindness06.02.02.003; 14.12.03.001--
Oedema14.05.06.010; 08.01.07.006--Not Available
Osteoporosis14.04.04.002; 15.02.03.0020.001654%
Pancreatitis07.18.01.001--
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages